Real-time enrollment status for this primary immune thrombocytopenia clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 4:46 AM UTC
| NCT Number | NCT07786077 |
| Recruiting Status | Recruiting |
| Condition | Primary Immune Thrombocytopenia |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | August 25, 2026 (6 days ago) |
As of August 31, 2026: Clinical trial NCT07786077 is currently recruiting participants. This clinical trial study for primary immune thrombocytopenia is actively seeking new participants at 1 location across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07786077 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07786077 was last updated 6 days ago (August 25, 2026). HelloStudys verifies this status automatically.